tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corinne Jenkins, 80 are a BUY (55.17%), 16 are a SELL (11.03%), 49 are a HOLD (33.79%).
Analyst Corinne Jenkins, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 55.87% that have a potential upside of 29.64% achieved within 179 days.
Corinne Jenkins’s has documented 249 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on IDYA, Ideaya Biosciences at 14-Apr-2026.
Analyst best performing recommendations are on AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES) at 9/13/2023. The price target of $10 was fulfilled within 1 day with a profit of $1.16 (10.39%) receiving and performance score of 103.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-May-2024
$18
2 years 1 months 11 days ago
(30-May-2024)
1/1 (100%)
$-1.51 (-7.74%)
19
Hold Since 08-Jul-2020
$10
$-20 (-66.67%)
4 years 17 days ago
(24-Jun-2022)
11/12 (91.67%)
$-19.79 (-66.43%)
649
Hold Since 23-May-2022
$10
$-20 (-66.67%)
$7
4 years 17 days ago
(24-Jun-2022)
0/2 (0%)
$-19.79 (-66.43%)
Hold Since 08-Jun-2022
$8
$-22 (-73.33%)
4 years 1 months 3 days ago
(08-Jun-2022)
1/2 (50%)
$-29.27 (-78.54%)
908
Hold Since 11-Dec-2021
$8
$-22 (-73.33%)
4 years 1 months 17 days ago
(24-May-2022)
4/5 (80%)
$-26.18 (-76.59%)
1047
Which stock is Corinne Jenkins is most bullish on?
Which stock is Corinne Jenkins is most reserved on?
What Year was the first public recommendation made by Corinne Jenkins?
